Pathophysiology and Animal Models of Schizophrenia

被引：0
|
作者：
Dawe, Gavin S. [1 ]
Hwang, Ern Huei Joel [1 ]
Tan, Chay Hoon [1 ]
机构：
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Clin Res Ctr, Dept Pharmacol, Singapore 117597, Singapore
来源：
ANNALS ACADEMY OF MEDICINE SINGAPORE | 2009年 / 38卷 / 05期
基金：
英国医学研究理事会;
关键词：
Animal models; Pharmacotherapy; Schizophrenia; MOUSE MODEL; COGNITIVE DYSFUNCTION; HEALTHY-VOLUNTEERS; CHAKRAGATI MOUSE; GENES; DOPAMINE; DISC1; MICE; INHIBITION; KETAMINE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Animal models of schizophrenia are important for research aimed at developing improved pharmacotherapies. In particular, the cognitive deficits of schizophrenia remain largely refractory to current medications and there is a need for improved medications. We discuss the pathophysiology of schizophrenia and in particular the possible mechanisms underlying the cognitive deficits. We review the current animal models of schizophrenia and discuss the extent to which they meet the need for models reflecting the various domains of the symptomatology of schizophrenia, including positive symptoms, negative symptoms and cognitive symptoms.
引用
收藏
页码：425 / 430
页数：6
相关论文
共 50 条
  • [1] Sex differences in animal models of schizophrenia shed light on the underlying pathophysiology
    Hill, Rachel Anne
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 67 : 41 - 56
  • [2] NEW INSIGHTS INTO THE PATHOPHYSIOLOGY, TREATMENT AND PREVENTION OF SCHIZOPHRENIA GLEANED FROM ANIMAL MODELS
    Grace, Anthony
    Lodge, Daniel
    Du, Yijuan
    Gill, Kathryn
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S55 - S55
  • [3] Redox Dysregulation in the Pathophysiology of Schizophrenia and Bipolar Disorder: Insights from Animal Models
    Kulak, Anita
    Steullet, Pascal
    Cabungcal, Jan-Harry
    Werge, Thomas
    Ingason, Andres
    Cuenod, Michel
    Do, Kim Quang
    ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (12) : 1428 - 1443
  • [4] A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice
    Dean, O. M.
    van den Buuse, M.
    Bush, A. I.
    Copolov, D. L.
    Ng, F.
    Dodd, S.
    Berk, M.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (23) : 2965 - 2976
  • [5] How Can We Justify the Use of Lower Animal Models to Understand the Pathophysiology of Schizophrenia?
    Boutillier, Anne-Laure
    Macedo, Carlos Eduardo
    Angst, Marie-Josee
    Sandner, Guy
    ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, 2008, : 577 - 582
  • [6] Animal models of schizophrenia
    Jones, C. A.
    Watson, D. J. G.
    Fone, K. C. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) : 1162 - 1194
  • [7] Animal models of schizophrenia
    De Hert, M
    Ellenbroek, B
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 2000, 26 (03) : 279 - 288
  • [8] Animal models for schizophrenia
    Wolterink, G
    Daenen, EWPM
    Van Ree, JM
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 2000, 27 (03) : 143 - 154
  • [9] Animal models of schizophrenia
    Moore, Holly
    SCHIZOPHRENIA RESEARCH, 2014, 160 (1-3) : E9 - E10
  • [10] Tardive dyskinesia: Pathophysiology and animal models
    Casey, DE
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 : 5 - 9
12345